needed effects
procainamide
active ingredient
procanbid
unwanted side effects
medical attention
following side effects
taking procainamide
check
doctor
nurse
following symptoms of overdose
taking procainamide
emergency help
procainamide side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
side effects of procainamide
active ingredient
procanbid
serum levels of the parent compound
metabolite
n-acetylprocainamide
napa
side effects
levels
mg per liter
mg per liter
mg per liter
side effects
patients with renal insufficiency
cardiovascular
side effects
hypotension
polymorphous ventricular tachycardia
asystole
administration of intravenous procainamide
active ingredient
procanbid
dosages
mg/min
risk of hypotension
patients with low blood pressure
cardiac dysfunction
procainamide
qt
interval lengthening
torsades de pointes
quinidine
possible negative inotropic side effects of procainamide
high serum levels
patients
compromised cardiac function
procainamide
formation of a
circulating immunoglobulin
coagulation factors
deep venous thrombosis
elevation in the partial thromboplastin time
case of myocarditis without pericarditis
several cases of pericarditis
procainamide
association with a lupus-like syndrome
cases of procainamide-induced agranulocytosis
complaints of sore throat
malaise
fever
evaluation of the complete blood count
differential cell count
rare cases of serious infection
death
problem
case of pure red cell aplasia
procainamide
active ingredient
procanbid
rechallenge
hematologic side effects
overall incidence of blood dyscrasias
affected patients
receiving procan sr
blood dyscrasia
diagnosis of agranulocytosis
granulocytopenia
neutropenia
leukopenia
thrombocytopenia
pancytopenia
bone marrow suppression
aplastic anemia
severity
reversible dyscrasias
drug levels
periodic monitoring of the complete blood count
careful attention
minor signs of infection during procainamide therapy
addition
lupus anticoagulants
patients with systemic lupus erythematosus
patients
procainamide in the absence of other lupus-like symptoms
presence of such immunoglobulins
thromboembolic complications
hypersensitivity reactions
reports of angioedema
urticarial rash
pruritus
such reactions
patients with a sulfite sensitivity
procainamide-induced hepatitis
immunologic side effects
lupus-like syndrome
chronic use of procainamide
active ingredient
procanbid
production of an antinuclear antibody
ana
asymptomatic patients after weeks of therapy
antibody
reversible lupus-like syndrome
myalgias
arthralgias
arthritis
pericardial serositis
rare cases
symptoms
affected patients
checking
ana titer
other month
quarterly
many clinicians
drug in some patients with a positive ana titer
taking into account
need for procainamide therapy
lupus-like syndrome
arthralgias
fever
chills
myalgias
pericarditis
pleuritis
pleural effusion
hemorrhagic cardiac tamponade
nephritis
cerebritis
periodic monitoring
high antinuclear antibody
ana
titer
patient
lupus-like symptoms
reevaluation of the use of procainamide
consideration of aspirin
corticosteroid therapy
lupus-like syndrome
procainamide
predilection for females
discontinuation of procainamide
slow acetylators
gastrointestinal side effects
nausea
vomiting
anorexia
diarrhea
nervous system
side effects
case reports of dizziness
tremors
rare cases of reversible peripheral neuropathy
procainamide-induced lupus-like syndrome
musculoskeletal weakness
patients
underlying myasthenia gravis
mg
case of respiratory failure
necrotizing myopathy with diaphragmatic involvement in an elderly patient without evidence of mg
year-old man with post-coronary artery bypass
grafting supraventricular arrhythmias
upper body
symmetrical muscle weakness
tenderness
weeks
beginning procainamide
associated findings
exudative pleural effusion
elevated creatinine kinase levels
positive anti-double stranded dna
anti-histone antibodies
renal function
antinuclear antibodies
procainamide was withdrawn.
patient
weakness
days
diaphragmatic weakness
respiratory acidosis
need for mechanical ventilation
extensive neuromuscular work-up
necrotizing myopathy
evidence of impaired neuromuscular junction transmission
muscle biopsy
inflammatory infiltrates
antinuclear antibodies
patient
next month
case of reversible mania
patient with nontoxic serum procainamide
active ingredient
procanbid
levels
year-old female undergoing
mitral valve replacement
tricuspid valve repair
experiencing
experiencing visual hallucinations
other symptoms
psychosis
days
beginning procainamide
hours
discontinuing procainamide
patient
normal sensorium
psychiatric side effects
euphoria
hallucinations
psychosis
mental depression
cases of procainamide-induced granulomatous hepatitis
intrahepatic cholestasis
cases
fever
vomiting
pruritus
none
lymphadenopathy
onset of signs
symptoms of liver dysfunction
days after drug administration
day
several months after drug withdrawal
mechanism of injury
procainamide-induced hepatitis
hepatic side effects
rare cases of reversible cholestatic jaundice
procainamide
cases
hypersensitivity reactions
frequent monitoring of liver function tests
patients with hepatic insufficiency
side effects of procanbid
fda
healthcare professional for medical advice
fever and chills
joint pain
swelling
pains with breathing
skin rash
itching
bleeding
blistering
burning
coldness
discoloration of skin
feeling of pressure
hives
infection
inflammation
itching
lumps
numbness
pain
rash
redness
scarring
soreness
swelling
tenderness
tingling
warmth at the injection site
confusion
fever
sore mouth
gums
throat
hallucinations
seeing
hearing
feeling things
mental depression
unusual bleeding
bruising
unusual tiredness
weakness
decrease in urination
dizziness
fainting
drowsiness
irregular heartbeat
nausea and vomiting
diarrhea
hardening
thickening of the skin
needle
loss of appetite
dizziness or lightheadedness